In The News

In Law360, Health Care Attorneys Examine CMS Proposed Rule for Value-Based Purchasing Arrangements

Practices: Health Care, Managed Care, Life Sciences, Health Care Finance & Restructuring, Digital Health, Regulatory Enforcement & Civil Litigation

The Centers for Medicare & Medicaid Services issued a proposed rule that, if finalized, would modify significantly the current Medicaid Drug Rebate Program regulations. The proposed rule puts forth new regulatory policies, as well as provides clarification with regard to already established policies, intended to encourage drug manufacturers and states to participate in value-based purchasing arrangements.

In a Law360 article, health care partner Tom Bulleit and health care associates Scott Falin (both of Washington, D.C.) and Joanna Hwang (New York) summarize key elements of the proposed rule and its implications.

Cookie Settings